ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Watson Pharmaceuticals is setting up a global R&D technology center in North Brunswick, N.J., leasing space from the New Jersey Economic Development Authority. The firm plans to invest about $4.5 million to outfit its new facility, which will include product development and analytical labs. It will focus on developing generic drugs, particularly for inhalation and respiratory products. When completed in the spring of 2012, the center will employ about 50 scientists, engineers, and support staff.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter